Arena Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.12 | -100% | -15.75 | -100% |
| P/S |
|
112540 | 4.09 | 2750735.09% |
|
|
| P/BV |
|
9.16 | 9.64 | -4.95% |
|
|
| P/FCF |
|
-11.8 | 52.09 | -122.65% |
|
|
| Ev/Ebitda |
|
0.3315 | 17.28 | -98.08% |
|
|
| Ev/S |
|
52.4 | 4.4 | 1090.73% |
|
|
| Ev/FCF |
|
0.3507 | 58.35 | -99.4% |
|
|
| E/P |
|
-0.0999 | 0.0339 | -394.95% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1.01 | 20.69 | -104.88% | -247134.71 | -100% |
| ROE |
|
-70.3 | -89.27 | -21.25% |
|
|
| ROA |
|
-62.41 | 6.91 | -1002.71% |
|
|
| ROIC |
|
0 | 12.56 | -100% |
|
|
| ROS |
|
17611.43 | 10.78 | 163286.18% |
|
|
| ROCE |
|
-77.52 | 13.91 | -657.26% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0745 | 2.89 | -102.58% | -0.0813 | -8.33% |
| Nеt Debt/Ebitda |
|
0.3316 | 3.67 | -90.96% |
|
|
| Debt/Ratio |
|
0.0525 | 0.2751 | -80.92% |
|
|
| Debt/Equity |
|
2.16 | 5.17 | -58.29% |
|
|
| Debt/Net Income |
|
-0.0668 | 6.84 | -100.98% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.5894 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0 | 0% |
|
|
| DSI |
|
0 | 0 | 0% |
|
|
| Average dividend growth |
|
0 | 0 | 0% |
|
|
| Average percentage for 5 years |
|
0 | 0 | 0% |
|
|
| Average percentage for payments |
|
0 | 80.02 | -100% |
|
|
| Difference from average difference in sector |
|
-1.5894 | 0 | 0% |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-119.44 | -28.88 | 313.57% |
| Growth impulse Ebitda 5 years |
|
324.81 | -79.88 | -506.62% |
| Growth impulse Net Income 5 years |
|
1996.6 | -75.91 | -2730.22% |
| Growth impulse FCF 5 years |
|
293.53 | -81.48 | -460.25% |
| Growth impulse EPS 5 years |
|
1506.4 | -56.51 | -2765.72% |
IP Score
4.6/10
